Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Jazz Pharmaceuticals' tremor drug fails to meet main goal in mid-stage study
07:57am, Thursday, 20'th Jun 2024
Jazz Pharmaceuticals said on Thursday its experimental drug to treat a neurological condition that causes involuntary and rhythmic shaking failed to meet the main goal in a mid-stage study.
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
07:45am, Thursday, 20'th Jun 2024
DUBLIN , June 20, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 2b clinical trial (NCT05122650) evaluating the efficacy and safety of su
3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition
06:13am, Friday, 14'th Jun 2024
If this year's market volatility has left you reeling, you're not alone. But, despite the high valuations plaguing many tech stocks, plenty of top-tier, high-quality blue-chip stocks are waiting in th
7 Overlooked Stocks Offering Long-Term Stability From the Shadows
02:27pm, Monday, 03'rd Jun 2024
Finding overlooked stocks (worth investing in) is tough in today's market. While you can screen for micro-caps, pink sheet stocks, and similar speculative investments, most of the best blue-chip and l
Zanidatamab demonstrated a median overall survival (OS) of 15.5 months in patients with centrally confirmed immunohistochemistry (IHC) 2+ or 3+ and a median OS of 18.1 months in patients with IHC 3+
Why Is Jazz (JAZZ) Down 3.5% Since Last Earnings Report?
12:36pm, Friday, 31'st May 2024
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock?
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
07:30am, Thursday, 30'th May 2024
Thirteen abstracts, including five late-breaking abstracts, underscore Jazz's ongoing commitment to advancing the understanding and treatment of serious sleep disorders Oral presentation of XYLO study
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
04:15pm, Wednesday, 29'th May 2024
DUBLIN , May 29, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences: Jefferies Global Healthca
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer
07:45am, Wednesday, 29'th May 2024
Target Action (PDUFA) Date set for November 29, 2024 If approved, zanidatamab will be the first HER2-targeted treatment specifically indicated for patients with HER2+ locally advanced or metastatic bi
3 Cannabis Stocks to Buy Now: May 2024
10:09am, Sunday, 26'th May 2024
Now that the federal government is finally taking action on cannabis rescheduling — moving it to Schedule III and creating de facto medical cannabis legalization — many are wondering about the sta
7 Blue-Chip Stocks to Buy Now: May 2024
06:00am, Thursday, 23'rd May 2024
If the market's dramatic shifts this year have left you feeling unsettled, you're not alone. Despite widespread overvaluation in many tech stocks, plenty of blue-chip stocks to buy can provide the por
DUBLIN , May 22, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced a strategic collaboration with Life Science Cares to drive social impact through employee volunteerism in
3 Cheap Blue-Chip Stocks to Buy Now: May 2024
02:32pm, Friday, 17'th May 2024
If the market's dramatic shifts this year leave you discombobulated, you're not alone. But, despite widespread overvaluation across a range of tech stocks, plenty of cheap blue-chip stocks are ready t
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
09:19am, Thursday, 09'th May 2024
Among the emerging industries that have captured the attention of investors is the cannabis sector. The cannabis industry has experienced remarkable growth, giving rise to a new breed of top cannabis
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
04:30pm, Wednesday, 08'th May 2024
Whispers and rumors of widespread cannabis legalization are growing louder. Although the last major surge in top cannabis stocks during the late 2010s significantly eclipses today's market and per-sha
